NZ295546A - Parenteral medicament containing n-{4-[2-1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)-ethyl]-phenyl}- 9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide, surfactant, and buffer - Google Patents

Parenteral medicament containing n-{4-[2-1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)-ethyl]-phenyl}- 9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide, surfactant, and buffer

Info

Publication number
NZ295546A
NZ295546A NZ295546A NZ29554695A NZ295546A NZ 295546 A NZ295546 A NZ 295546A NZ 295546 A NZ295546 A NZ 295546A NZ 29554695 A NZ29554695 A NZ 29554695A NZ 295546 A NZ295546 A NZ 295546A
Authority
NZ
New Zealand
Prior art keywords
isoquinolinyl
dimethoxy
tetrahydro
dihydro
oxo
Prior art date
Application number
NZ295546A
Inventor
Wei Qin Tong
Mickey Lee Wells
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of NZ295546A publication Critical patent/NZ295546A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ295546A 1994-10-05 1995-10-04 Parenteral medicament containing n-{4-[2-1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)-ethyl]-phenyl}- 9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide, surfactant, and buffer NZ295546A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31830894A 1994-10-05 1994-10-05
PCT/US1995/012952 WO1996011007A1 (en) 1994-10-05 1995-10-04 Parenteral pharmaceutical compositions containing gf120918a

Publications (1)

Publication Number Publication Date
NZ295546A true NZ295546A (en) 1999-01-28

Family

ID=23237614

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ295546A NZ295546A (en) 1994-10-05 1995-10-04 Parenteral medicament containing n-{4-[2-1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)-ethyl]-phenyl}- 9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide, surfactant, and buffer

Country Status (12)

Country Link
EP (1) EP0784474A2 (en)
JP (1) JPH10507177A (en)
KR (1) KR970705997A (en)
AU (1) AU702519B2 (en)
BR (1) BR9509251A (en)
CA (1) CA2201628A1 (en)
CZ (1) CZ104197A3 (en)
HU (1) HUT77883A (en)
NZ (1) NZ295546A (en)
PL (1) PL319511A1 (en)
RU (1) RU2157687C2 (en)
WO (1) WO1996011007A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9710612D0 (en) * 1997-05-23 1997-07-16 Glaxo Group Ltd Synthesis of acridine derivatives
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
US5922754A (en) * 1998-10-02 1999-07-13 Abbott Laboratories Pharmaceutical compositions containing paclitaxel
MA26696A1 (en) 1998-10-08 2004-12-20 Smithkline Beecham Plc NOVEL TETRAHYDROBENZAZEPINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AT408186B (en) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag AQUEOUS PREPARATION OF BETA CAROTINE
DK1189637T3 (en) 1999-05-17 2006-12-11 Cancer Res Ventures Ltd Products to improve the bioavailability of orally administered drugs
US6521635B1 (en) 2000-01-20 2003-02-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of MXR transport by acridine derivatives
IL153676A0 (en) * 2000-06-30 2003-07-06 Inex Pharmaceuticals Corp Liposomal pharmaceutical compositions
WO2003002150A1 (en) * 2001-06-28 2003-01-09 Wyeth Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma
KR100866728B1 (en) * 2004-11-12 2008-11-03 주식회사종근당 The injection of tacrolimus
FR2948568B1 (en) * 2009-07-30 2012-08-24 Sanofi Aventis PHARMACEUTICAL FORMULATION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2783680B2 (en) * 1991-01-11 1998-08-06 ラボラトワール、グラクソ、ソシエテ、アノニム Acridine derivative

Also Published As

Publication number Publication date
CA2201628A1 (en) 1996-04-18
MX9702473A (en) 1997-07-31
JPH10507177A (en) 1998-07-14
WO1996011007A1 (en) 1996-04-18
AU702519B2 (en) 1999-02-25
KR970705997A (en) 1997-11-03
CZ104197A3 (en) 1997-09-17
PL319511A1 (en) 1997-08-18
BR9509251A (en) 1997-10-21
RU2157687C2 (en) 2000-10-20
HUT77883A (en) 1998-09-28
EP0784474A2 (en) 1997-07-23
AU3891395A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
GB2287559B (en) Parallel processor change-apparatus and method
PL314788A1 (en) Chilling tank and end frame thereof
IT1277966B1 (en) PROCEDURE AND APPARATUS FOR THE SELECTION OF PERSONAL ATTRIBUTES WITH DELAY MANAGEMENT
PL324291A1 (en) Anthropodicidal and fungicidal cyclic amides
IT1277968B1 (en) PROCEDURE AND APPARATUS FOR THE SELECTION AND MANAGEMENT OF PERSONAL ATTRIBUTES WITH THE USE OF A PREFERENCE MEMORY
EP0744575A4 (en) Framed structure
NZ295546A (en) Parenteral medicament containing n-{4-[2-1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)-ethyl]-phenyl}- 9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide, surfactant, and buffer
GB9418709D0 (en) Secure computer network
ZA951744B (en) Acetamides
AU124289S (en) Multimedia personal computer with integrated monitor
HU9602798D0 (en) Benzamide derivative, compositions containing said derivative and use thereof
PL307146A1 (en) Personal computer
ZA959996B (en) Enterokinetic benzamide
ZA959517B (en) Leutherobin and analogs thereof
EP0714890A3 (en) Process and the preparation of 4-amino-2,2,6,6-tetra-methyl piperidine
GB9402512D0 (en) Carton and carton hinge construction
IL114305A0 (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters and their use
GB9506296D0 (en) "Power tong with improved guard and method"
EP0697689A3 (en) Integrated computer and television
ZA923814B (en) Gingerol and gingerdiol derivatives as hypocholesterolemic and antiatherosclerotic agents
IL114688A0 (en) Vectors and transformed host cells
EP0799225A4 (en) Compounds and methods
GB9426180D0 (en) Lateral and frontal head support
ZA9510305B (en) Heterocyclic amides
GB9502180D0 (en) Secure computer hardware case